Keith Allen Robinson

Title: The Innovative Contributions of Keith Allen Robinson

Introduction

Keith Allen Robinson, an accomplished inventor based in Norcross, GA, has made significant strides in the field of therapeutic angiogenesis. With two patents to his name, Robinson’s work focuses on methods that enhance vascularization in diseased or damaged tissues, showcasing his commitment to advancing medical technology.

Latest Patents

Robinson's latest patent, titled "Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue," details innovative methods for forming new blood vessels in a subject's diseased or damaged tissue. This invention outlines a crucial process comprising two main steps: isolating autologous bone marrow-mononuclear cells from the subject and transplanting these cells locally into the affected area. This approach effectively fosters the development of new blood vessels, which can be critical in areas suffering from ischemia. The methods also propose ways to increase blood flow and enhance angiogenesis in diseased tissues, demonstrating significant potential for treating various conditions involving tissue injury.

Career Highlights

Robinson has established a notable career at Boston Scientific Scimed, Inc., where he collaborates with some of the brightest minds in the medical field. His contributions are pivotal in pushing the boundaries of how angiogenesis can be harnessed through innovative cell transplantation techniques.

Collaborations

Throughout his career, Robinson has worked alongside talented colleagues, including Takafumi Ueno and Toyoaki Murohara. These collaborations emphasize the importance of teamwork in driving forward groundbreaking medical research and development.

Conclusion

Keith Allen Robinson's work represents a remarkable intersection of innovation and applied science in the field of therapeutic medical interventions. His patents not only contribute to advancements in treatment methodologies but also signify the role of dedicated inventors in improving patient outcomes through technology. As he continues to innovate, the potential to transform healthcare through angiogenesis methods remains promising.